1 / 2

HIV Drugs Market

Increasing HIV/AIDS prevalence especially in low and middle-income countries is one of the major factors in boosting the global HIV drugs market.

Rachana1
Download Presentation

HIV Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV Drugs Market Global Key Players, Trends, Share, Industry Size, Segmentation, Forecast To 2030 Increasing HIV/AIDS prevalence especially in low and middle-income countries is one of the major factors in boosting the global HIV drugs market. The number of people receiving HIV treatment is increasing as they are becoming more aware of the infection and its drug treatment options. In addition, the development of HIV therapeutics and medical trials, and product launches are the factors driving the growth of the market. Also, the government initiatives in creating awareness amongst the population to prevent and manage HIV to reduce the economic burden is further supporting the HIV drugs market expansion. The global HIV drugs market peaked at ~US$ 30.89 billion in 2021. The market is expected to witness a CAGR of ~6.25 from 2022 to 2030. Although there is no cure for the human deficiency virus (HIV) infection, it can lead to the development of acquired immunodeficiency syndrome (AIDS). Therefore, many key players in are now focusing on developing revolutionary therapies with the aim to end the epidemic by introducing effective and lifesaving drugs. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/hiv-drugs-market/7792 Despite all these measures and awareness, certain restraints and challenges are hindering the growth of the global HIV drugs market. These barriers include side effects associated with HIV drugs, stringent government approval of these drugs, and low awareness of these therapeutics in emerging markets. It has been observed that HIV drugs often cause side effects such as headaches, depression, nausea, vomiting, and abdominal pain, because of which many individuals stop using these treatments. This will limit the growth of the HIV drugs market. Key Players: •Mylan N.V. •AbbVie Inc. •Bristol-Myers Squibb Company •ViiV Healthcare Limited •Genentech, Inc. •Gilead Sciences, Inc. •Merck & Co. •Boehringer Ingelheim International GmbH

  2. •GlaxoSmithKline plc •Janssen Pharmaceuticals, Inc. HIV Drugs Market by Drug Class •Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) •Integrase Inhibitors •Combination Drugs Browse the full report now: https://growthplusreports.com/report/hiv-drugs- market/7792 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

More Related